Del Gaizo Moore, V., Brown, J. R., Certo, M., Love, T. M., Novina, C. D., & Letai, A. (2007). Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. American Society for Clinical Investigation.
Citação norma ChicagoDel Gaizo Moore, Victoria, Jennifer R. Brown, Michael Certo, Tara M. Love, Carl D. Novina, and Anthony Letai. Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737. American Society for Clinical Investigation, 2007.
MLA CitationDel Gaizo Moore, Victoria, et al. Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737. American Society for Clinical Investigation, 2007.